| Phytochemical Name : gamma-Tocotrienol |
| PCNDIDG0028 |
| Pubchem CID : 5282349 |
| Molecular formula: C28H42O2 |
| Canonical SMILES : CC1=C(C=C2CCC(OC2=C1C)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O |
Synonymes : gamma-Tocotrienol|14101-61-2|D-gamma-Tocotrienol|Plastochromanol|7,8-Dimethyltocotrienol|Gama-Tocotrienol|Plastochromanol 3|.gamma.-Tocotrienol|D-.gamma.-Tocotrienol|(R)-.gamma.-Tocotrienol|UNII-185QAE24TR|185QAE24TR|CHEBI:33277|(2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol|(R)-2,7,8-Trimethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)chroman-6-ol|(R-(E,E))-3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol|2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, (R-(E,E))-|2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-, [R-(E,E)]-|2H-1-benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)-|2R,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol|gammaTocotrienol|gamma Tocotrienol|gamma -Tocotrienol|2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,7,8-TRIMETHYL-2-((3E,7E)-4,8,12-TRIMETHYL-3,7,11-TRIDECATRIEN-1-YL)-, (2R)-|2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,7,8-TRIMETHYL-2-((3E,7E)-4,8,12-TRIMETHYL-3,7,11-TRIDECATRIENYL)-, (2R)-|2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-, (2R)-|Gamma-T3|2R-gamma-tocotrienol|(R)-gamma-Tocotrienol|D09YBF|BIDD:PXR0016|gammaTocotrienolPlastochromanol|CHEMBL120697|SCHEMBL3272929|SCHEMBL16430897|DTXSID101019984|HMS3650C14|GAMMA TOCOTRIENOL [WHO-DD]|3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol|Gamma-tocotrienol (prostate cancer)|LMPR02020057|gamma-Tocotrienol, analytical standard|AKOS040744431|2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-tr imethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI)|J13.903C|HY-108694|CS-0029988|D-gamma-Tocotrienol, analytical reference material|SR-01000946268|SR-01000946268-1|Q15633932|Gamma-tocotrienol (prostate cancer), Davos Life Science|(R)-2,7,8-trimethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)chroman-6-ol|6-Chromanol, 2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-|6-Chromanol, 2,7,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)- (7CI,8CI)|(2R)-2,7,8-trimethyl-2-(4',8',12'-trimethyl-trideca-3',7',11'-trienyl)-6-hydroxychroman|(2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol|(r)-2,7,8-trimethyl-2-((3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl) chroman-6-ol|153831-49-3|2,7,8-TRIMETHYL-2-[(3E,7E,11E,15E,19E,23E,27E)-4,8,12,16,20,24,28,32-O CTAMETHYL-3,7,11,15,19,23,27,31-TRITRIACONTAOCTAENYL]-6-CHROMANOL|2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI) |
| Structure | |
| 3D structure | 2D structure |
![]() |
| Log Po/w (iLOGP) : 5.400 |
| Log Po/w (XLOGP3) : 8.940 |
| Log Po/w (WLOGP) : 8.290 |
| Log Po/w (MLOGP) : 5.680 |
| Log Po/w (SILICOS-IT) : 8.710 |
| Consensus Log Po/w : 7.400 |

